logo
logo

Drug Discovery Startup Peptris Raises $1 Million Funding From Speciale Invest, Others

Dec 19, 2023•over 1 year ago

Amount Raised

$1 Million

Round Type

seed

BengaluruBiotechnology Research

Description

Peptris Technologies, a Bengaluru-based artificial intelligence-powered drug discovery company, on Tuesday announced it has raised $1 million in a pre-seed funding round led by Speciale Invest. The company did not disclose the names of other investors in the round or the valuation at which the funds were raised.

Company Information

Company

Peptris Technologies

Location

Bengaluru, Karnataka, India

About

Peptris is an AI powered preclinical drug discovery company working on oncology, inflammation and rare diseases. At Peptris, we have created an array of AI models to predict various parameters that are critical for a novel molecule to be considered a potential drug candidate. All these models are orchestrated by an automated pipeline that prunes large purchasable compound datasets to identify potential hits and also creates denovo variations of compounds that are predicted to be novel, potent, safe, selective, and active clinically. The pipeline ensures that the number of compounds to be tested and validated in a wet lab are minimal, making our discovery efficient, faster and cost effective. We have some exciting wet lab results from our proprietary discovery programs and we are currently accelerating them into preclinical development.

Related People